FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans-Jochem Kolb

Research Profile

Procedures

Disorders

Concepts & Ideas

Living Beings

Dogs

Anatomy

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Andreas Kremser; T Kroell; S Kufner; Andreas Hausmann; Hans-Jochem Kolb; Elke Konhaeuser; Johanna Tischer; Horst Zitzelsberger; Helga Schmetzer
Combined immunophenotyping and fluorescence in situ hybridization with chromosome-specific DNA probes allows quantification and differentiation of ex vivo generated dendritic cells, leukemia-derived dendritic cells and clonal leukemic cells in patients with acute myeloid leukemia.
Tim Pfeiffer; Christof Scheid; Michael Schleuning; Günter Schlimok; Susanne Schnittger; Karsten Spiekermann; Johanna Tischer; Jan Braess; Stefanie Buchholz; Gesine Bug; Donald Bunjes; Maximilian Christopeit; Arnold Ganser; Hildegard Greinix; Karl-Heinz Haude; Ernst Holler; Hans-Jochem Kolb; Jiri Mayer; Ralf G Meyer; Christoph Schmid
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.
Ting Yang; Zhi-zhe Chen; Hans-Jochem Kolb; Raymund Buhmann
A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans-Jochem Kolb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andreas Kremser; T Kroell; S Kufner; Andreas Hausmann; Hans-Jochem Kolb; Elke Konhaeuser; Johanna Tischer; Horst Zitzelsberger; Helga Schmetzer
Combined immunophenotyping and fluorescence in situ hybridization with chromosome-specific DNA probes allows quantification and differentiation of ex vivo generated dendritic cells, leukemia-derived dendritic cells and clonal leukemic cells in patients with acute myeloid leukemia.
Leukemia & lymphoma 2013;54(6):1297-308.
2013: Tim Pfeiffer; Christof Scheid; Michael Schleuning; Günter Schlimok; Susanne Schnittger; Karsten Spiekermann; Johanna Tischer; Jan Braess; Stefanie Buchholz; Gesine Bug; Donald Bunjes; Maximilian Christopeit; Arnold Ganser; Hildegard Greinix; Karl-Heinz Haude; Ernst Holler; Hans-Jochem Kolb; Jiri Mayer; Ralf G Meyer; Christoph Schmid
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.
Haematologica 2013;98(4):518-25.
2013: Ting Yang; Zhi-zhe Chen; Hans-Jochem Kolb; Raymund Buhmann
A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Immunobiology 2013;218(4):548-53.
2013: Susanne Reuther; Helga Schmetzer; Friedhelm R Schuster; Arndt Borkhardt; Christine Grabrucker; Hans-Jochem Kolb; Pina Krell; T Kroell; Anja Liepert; Raymund Buhmann
In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping.
Clinical and experimental medicine 2013;13(1):29-48.
2013: Stefan Burdach; Hans-Jochem Kolb
The vigor of defense against non-self: potential superiority of allorestricted T cells in immunotherapy of cancer?
Frontiers in oncology 2013;3():100.
2013: D Bund; F Gökmen; Hans-Jochem Kolb; Raymund Buhmann; J Zorn; Helga Schmetzer
Minor histocompatibility antigen UTY as target for graft-versus-leukemia and graft-versus-haematopoiesis in the canine model.
Scandinavian journal of immunology 2013;77(1):39-53.
2012: Patrice Chevallier; Fabio Ciceri; Chistoph Faul; Juergen Finke; Arnold Ganser; Gaelle Guillerm; Anne Huynh; Hans-Jochem Kolb; Myriam Labopin; Bruno Lioure; Arnon Nagler; Emmanuelle Polge; Joerg Schubert; Stefanie Buchholz; Mohamad Mohty
Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT.
European journal of haematology 2012;89(3):214-9.
2012: Helge Menzel; Christian Peschel; Tibor Schuster; Hans-Jochem Kolb; Tobias Dechow; Katarzyna Hinmüller; Alexander Hoellein; Ulrich Keller
Efficacy of repeat myeloablative chemotherapy with autologous stem-cell support in multiple myeloma.
Therapeutic advances in hematology 2012;3(2):81-8.
2012: Andreas Hausmann; Wolfgang Hill; Hans-Jochem Kolb; Georg Ledderose; Hans-Joachim Stemmler; Andrea Baur-Melnyk; Susanne Fritsch; Sandra Geiger; Johanna Ullmann; Johanna Tischer
Bone loss after allogeneic haematopoietic stem cell transplantation: a pilot study on the use of zoledronic Acid.
Chemotherapy research and practice 2012;2012():858590.
2012: Andreas Moosmann; Wolfgang Hammerschmidt; Hans-Jochem Kolb
Virus-specific T cells for therapy--approaches, problems, solutions.
European journal of cell biology 2012;91(1):97-101.
2011: Julia Zorn; Heiko Adler; Werner Panzer; Sabine Schwamberger; Hans-Jochem Kolb
Transplantation of CD6-depleted peripheral blood stem cells after DLA-haploidentical bone marrow transplantation contributes to engraftment and tolerance in a preclinical model of stem cell transplantation.
Veterinary immunology and immunopathology 2011;144(1-2):27-35.
2011: Julia Dreyssig; Markus Freudenreich; Christine Grabrucker; Hans-Jochem Kolb; Andreas Kremser; T Kroell; S Kufner; Anja Liepert; Helmut Salih; Christoph Schmid; Nina Scholl; Johanna Tischer; Helga Schmetzer
Various 'dendritic cell antigens' are already expressed on uncultured blasts in acute myeloid leukemia and myelodysplastic syndromes.
Immunotherapy 2011;3(9):1113-24.
2011: Andreas Rank; Bettina Toth; Verena Pihusch; Ruth Delker; Erhard Hiller; Hans-Jochem Kolb; Rienk Nieuwland; Rudolf Pihusch
Microparticles for diagnosis of graft-versus-host disease after allogeneic stem transplantation.
Transplantation 2011;92(2):244-50.
2011: Gérard Socié; Matthias Stelljes; Liisa Volin; Axel R Zander; Hartmut Bertz; Wolfgang A Bethge; Martin Bornhäuser; Matthias Egger; Hermann Einsele; Jürgen Finke; Olga Grishina; Dominik A Heim; Ernst Holler; Hans-Jochem Kolb; Karin Kolbe; Vladimir Koza; Werner Linkesch; Johan A Maertens; Jiri Mayer; Hellmut D Ottinger; Tapani Ruutu; Claudia Schmoor; Rainer Schwerdtfeger
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Blood 2011;117(23):6375-82.
2011: Andreas Rank; Bettina Toth; Ralf Wilkowski; Verena Pihusch; Ruth Delker; Hans-Jochem Kolb; Rienk Nieuwland; Rudolf Pihusch
Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients.
Clinical transplantation 2011;25(3):E233-42.
2011: Ingeborg Laaser; Fabian J Theis; Martin Hrabé De Angelis; Hans-Jochem Kolb; Jerzy Adamski
Huge splicing frequency in human Y chromosomal UTY gene.
Omics : a journal of integrative biology 2011;15(3):141-54.
2011: Katharina E Lechner; Tilmann Pohl; Lars Lindner; Bernhard Heilmeier; Til Seiler; Friederike Mumm; Johanna Tischer; Karsten Spiekermann; Wolfgang M Franz; Susanna Müller; Hans-Jochem Kolb; Wolfgang Hiddemann; Jan Braess
Acute heart failure: when standard therapy fails--an interdisciplinary challenge.
International journal of cardiology 2011;147(1):160-2.
2011: Caroline M Wernicke; Hendrik Juenger; Peter Bader; Stefan Burdach; Michaela Doering; Thomas G P Grunewald; Ulrike Koehl; Hans-Jochem Kolb; Selim Kuci; Zyrafete Kuci; Anita Lawitschka; Ingo Mueller; Christina Peters; Irene von Luettichau
Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.
International archives of medicine 2011;4(1):27.
2010: Hans-Jochem Kolb
Obituary. In memoriam Stefan Thierfelder.
Annals of hematology 2010;89(11):1071.
2010: Petra Sostak; Claudio S Padovan; S Eigenbrod; Sigrun Roeber; Stephan Segerer; C Schankin; Sabine I Siegert; Tobias Saam; Diethilde Theil; Hans-Jochem Kolb; Hans A Kretzschmar; Andreas Straube
Cerebral angiitis in four patients with chronic GVHD.
Bone marrow transplantation 2010;45(7):1181-8.
2010: Anne M Dickinson; Kim F Pearce; Jean Norden; Stephen G O'Brien; Ernst Holler; Heike Bickeböller; Yesilda Balavarca; Vanderson Rocha; Hans-Jochem Kolb; Ilona Hromadnikova; Petr Sedlacek; Dietger Niederwieser; Ronald Brand; Tapani Ruutu; Jane Apperley; Richard Szydlo; Els Goulmy; Wolfgang Siegert; Theo de Witte; Alois Gratwohl
Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia.
Haematologica 2010;95(6):922-7.
2010: Andreas Moosmann; Iris Bigalke; Johanna Tischer; Leah Schirrmann; Julitta Kasten; Stefanie Tippmer; Marina Leeping; Dusan Prevalsek; Gundula Jaeger; Georg Ledderose; Josef Mautner; Wolfgang Hammerschmidt; Dolores J Schendel; Hans-Jochem Kolb
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.
Blood 2010;115(14):2960-70.
2010: Susanne Saussele; Michael Lauseker; Alois Gratwohl; Dietrich W Beelen; Donald Bunjes; Rainer Schwerdtfeger; Hans-Jochem Kolb; Anthony D Ho; Christiane Falge; Ernst Holler; Günter Schlimok; Axel R Zander; Renate Arnold; Lothar Kanz; Robert Dengler; Claudia Haferlach; Brigitte Schlegelberger; Markus Pfirrmann; Martin C Müller; Susanne Schnittger; Armin Leitner; Nadine Pletsch; Andreas Hochhaus; Joerg Hasford; Rüdiger Hehlmann
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.
Blood 2010;115(10):1880-5.
2010: Andreas Kremser; Julia Dressig; Christine Grabrucker; Anja Liepert; Tanja Kroell; Nina Scholl; Christoph Schmid; Johanna Tischer; Stefanie Kufner; Helmut Salih; Hans-Jochem Kolb; Helga Schmetzer
Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(2):185-99.
2010: Anja Liepert; Christine Grabrucker; Andreas Kremser; Julia Dreyssig; Christian Ansprenger; Markus Freudenreich; T Kroell; Roland Reibke; Johanna Tischer; Cornelia Schweiger; Christoph Schmid; Hans-Jochem Kolb; Helga Schmetzer
Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
Cellular immunology 2010;265(1):23-30.
2010: Dagmar Bund; Raymund Buhmann; Füsun Gökmen; Andreas Kremser; Julia Dreyssig; Hans-Jochem Kolb; Helga Schmetzer
Canine-DCs using different serum-free methods as an approach to provide an animal-model for immunotherapeutic strategies.
Cellular immunology 2010;263(1):88-98.
2009: Ulrike Bacher; Evgeny Klyuchnikov; Tatjana Zabelina; Hellmut Ottinger; Dietrich W Beelen; Hubert Schrezenmeier; Gerhard Ehninger; Carlheinz Müller; Jürgen Berger; Meinolf Suttorp; Hans-Jochem Kolb; Nicolaus Kröger; Axel R Zander
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Annals of hematology 2009;88(12):1237-47.
2009: Hans-Jochem Kolb; Belinda Simoes; Christoph Schmid
Stem cell transplants for patients with relapsed/refractory leukaemia.
Current opinion in hematology 2009;16(6):444-52.
2009: N Schinwald; Andreas Rank; Johanna Tischer; Hans-Jochem Kolb
[Steroid-refractory graft-versus-host disease: extracorporeal irradiation of leucocytes induces immunotolerance].
Der Internist 2009;50(11):1270-5.
2009: Jürgen Finke; Wolfgang A Bethge; Claudia Schmoor; Hellmut D Ottinger; Matthias Stelljes; Axel R Zander; Liisa Volin; Tapani Ruutu; Dominik A Heim; Rainer Schwerdtfeger; Karin Kolbe; Jiri Mayer; Johan A Maertens; Werner Linkesch; Ernst Holler; Vladimír Koza; Martin Bornhäuser; Hermann Einsele; Hans-Jochem Kolb; Hartmut Bertz; Matthias Egger; Olga Grishina; Gérard Socié
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
The lancet oncology 2009;10(9):855-64.
2009: Charalampia Kyriakou; Carmen Canals; Jürgen Finke; Guido Kobbe; Jean-Luc Harousseau; Hans-Jochem Kolb; Nicolas Novitzky; Anthony H Goldstone; Anna Sureda; Norbert Schmitz
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3951-8.
2009: Julia Zorn; Martin Herber; Sabine Schwamberger; Werner Panzer; Heiko Adler; Hans-Jochem Kolb
Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
Experimental hematology 2009;37(8):998-1006.
2009: Peter Valent; Wolf-Karsten Hofmann; Guntram Büsche; Karl Sotlar; Hans-Peter Horny; Detlef Haase; Torsten Haferlach; Wolfgang Kern; Peter Bettelheim; Christian Baumgartner; Wolfgang R Sperr; Thomas Nösslinger; Friedrich Wimazal; Aristoteles A Giagounidis; Michael Lübbert; Otto Krieger; Hans-Jochem Kolb; Reinhard Stauder; Michael Pfeilstöcker; Norbert Gattermann; Christa Fonatsch; Carlo Aul; Ulrich Germing
Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.
Annals of hematology 2009;88(7):607-11.
2009: C T Rieger; H Rieger; Hans-Jochem Kolb; L Peterson; S Huppmann; M Fiegl; Helmut Ostermann
Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(3):220-6.
2009: Nina Scholl; Julia Loibl; Andreas Kremser; Anja Liepert; Christine Grabrucker; Helmut R Salih; Hans-Jochem Kolb; Helga Schmetzer
The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders.
Leukemia & lymphoma 2009;50(3):427-36.
2009: Raymund Buhmann; B Simoes; M Stanglmaier; T Yang; M Faltin; D Bund; Horst Lindhofer; Hans-Jochem Kolb
Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion.
Bone marrow transplantation 2009;43(5):383-97.
2008: Hans-Jochem Kolb
Graft-versus-leukemia effects of transplantation and donor lymphocytes.
Blood 2008;112(12):4371-83.
2008: Johannes Schetelig; Martin Bornhäuser; Christoph Schmid; Bernd Hertenstein; Rainer Schwerdtfeger; Hans Martin; Matthias Stelljes; Ute Hegenbart; Kerstin Schäfer-Eckart; Monika Füssel; Barbel Wiedemann; Christian Thiede; Joachim Kienast; Herrad Baurmann; Arnold Ganser; Hans-Jochem Kolb; Gerhard Ehninger
Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5183-91.
2008: Kamran Ghoreschi; Peter Thomas; Marius Penovici; Johanna Ullmann; Christian Sander; Georg Ledderose; Gerd Plewig; Hans-Jochem Kolb; Martin Röcken
PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease.
European journal of dermatology : EJD 2008;18(6):667-70.
2008: Christina T Rieger; Helmut Ostermann; Hans-Jochem Kolb; Michael Fiegl; Saskia Huppmann; Nicole Morgenstern; Johanna Tischer
A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients.
Annals of hematology 2008;87(11):915-22.
2008: Armin Gerbitz; Patrick Hillemanns; Christoph Schmid; Andrea Wilke; Rajshri Jayaraman; Hans-Jochem Kolb; Gunther Eissner; Ernst Holler
Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(10):1180-9.
2008: Mary E D Flowers; Jane F Apperley; Koen van Besien; Ahmet Elmaagacli; Andrew Grigg; Vijay Reddy; Andrea Bacigalupo; Hans-Jochem Kolb; Luis Bouzas; Mauricette Michallet; H Miles Prince; Robert Knobler; Dennis Parenti; Jose Gallo; Hildegard T Greinix
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.
Blood 2008;112(7):2667-74.
2008: Friedhelm R Schuster; Raymund Buhmann; Susanne Reuther; Bernd Hubner; Christine Grabrucker; Anja Liepert; Roland Reibke; Peter Lichtner; Ting Yang; Tanja Kroell; Hans-Jochem Kolb; Arndt Borkhardt; Helga Schmetzer
Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.
Cancer genomics & proteomics 2008;5(5):275-86.
2008: Marlon R Schneider; Eckhard Wolf; Joachim Braun; Hans-Jochem Kolb; Heiko Adler
Canine embryo-derived stem cells and models for human diseases.
Human molecular genetics 2008;17(R1):R42-7.
2008: Christoph Schmid; Michael Schleuning; Marcus Hentrich; G E Markl; Armin Gerbitz; Johanna Tischer; Georg Ledderose; D Oruzio; Wolfgang Hiddemann; Hans-Jochem Kolb
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
Bone marrow transplantation 2008;41(8):721-7.
2008: Julia Hauer; Sabrina Tosi; Friedhelm R Schuster; Jochen Harbott; Hans-Jochem Kolb; Arndt Borkhardt
Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement.
Pediatric blood & cancer 2008;50(4):921-3.
2008: Charalampia Kyriakou; Carme Canals; Anthony Goldstone; Dolores Caballero; Bernd Metzner; Guido Kobbe; Hans-Jochem Kolb; Joachim Kienast; Peter Reimer; Jurgen Finke; Gunnar Oberg; Ann Hunter; Niklas Theorin; Anna Sureda; Norbert Schmitz
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):218-24.
2008: L K Ostronoff; Elisabeth Kremmer; M L Fermín; Cristina Fragío; J Mysliwietz; Hans-Jochem Kolb; Concepción Tejero
Canine stem cell factor augments expression of matrix metalloproteinase-9 by CD34 cells.
Cytotherapy 2008;10(2):193-202.
2007: Christoph Schmid; Myriam Labopin; Arnon Nagler; Martin Bornhäuser; Jürgen Finke; AB Fassas; Liisa Volin; Günham Gürman; Johan Maertens; Pierre Bordigoni; Ernst Holler; Gerhard Ehninger; Emmanuelle Polge; Norbert-Claude Gorin; Hans-Jochem Kolb; Vanderson Rocha
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4938-45.
2007: Ingrid G Schuster; Dirk H Busch; Elfriede Eppinger; Elisabeth Kremmer; Slavoljub Milosevic; Christine Hennard; Christina Kuttler; Joachim W Ellwart; Bernhard Frankenberger; Elfriede Nössner; Christoph Salat; Christian Bogner; Arndt Borkhardt; Hans-Jochem Kolb; Angela M Krackhardt
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies.
Blood 2007;110(8):2931-9.
2007: Marlon R Schneider; Heiko Adler; Joachim Braun; Beate Kienzle; Eckhard Wolf; Hans-Jochem Kolb
Canine embryo-derived stem cells--toward clinically relevant animal models for evaluating efficacy and safety of cell therapies.
Stem cells (Dayton, Ohio) 2007;25(7):1850-1.
2007: Eva M Weissinger; Eric Schiffer; Bernd Hertenstein; James L M Ferrara; Ernst Holler; Michael Stadler; Hans-Jochem Kolb; Axel Zander; Petra Zürbig; Markus Kellmann; Arnold Ganser
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Blood 2007;109(12):5511-9.
2007: Helga Schmetzer; A Kremser; J Loibl; T Kroell; Hans-Jochem Kolb
Quantification of ex vivo generated dendritic cells (DC) and leukemia-derived DC contributes to estimate the quality of DC, to detect optimal DC-generating methods or to optimize DC-mediated T-cell-activation-procedures ex vivo or in vivo.
Leukemia 2007;21(6):1338-41.
2007: Rüdiger Hehlmann; Ute Berger; Markus Pfirrmann; Hermann Heimpel; Andreas Hochhaus; Joerg Hasford; Hans-Jochem Kolb; Tanja Lahaye; Ole Maywald; Andreas Reiter; Dieter K Hossfeld; Christoph Huber; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Tobler; Christoph Nerl; Max Solenthaler; Mariele E Goebeler; Martin Griesshammer; Thomas Fischer; Stephan Kremers; Hartmut Eimermacher; Michael Pfreundschuh; Wolf-Dietrich Hirschmann; Klaus Lechner; Barbara Wassmann; Christiane Falge; Hartmut H Kirchner; Alois Gratwohl
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Blood 2007;109(11):4686-92.
2007: Christoph Schmid; Hans-Jochem Kolb
[Allogeneic stem cell transplantation in the management of acute myeloid leukemia].
Medizinische Klinik (Munich, Germany : 1983) 2007;102(4):317-23.
2007: Martin Weisser; Michael Schleuning; Claudia Haferlach; Rainer Schwerdtfeger; Hans-Jochem Kolb
Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy.
Leukemia & lymphoma 2007;48(2):295-301.
2006: N Hentschel; Matthias Krusch; Peter Kiener; Hans-Jochem Kolb; Helmut R Salih; Helga Schmetzer
Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
European journal of haematology 2006;77(2):91-101.
2006: Christoph Schmid; Michael Schleuning; Rainer Schwerdtfeger; Bernd Hertenstein; Eva Mischak-Weissinger; Donald Bunjes; Stephanie von Harsdorf; Christoph Scheid; Udo Holtick; Hildegard Greinix; Felix Keil; Barbara Schneider; Michael Sandherr; Gesine Bug; Johanna Tischer; Georg Ledderose; Michael Hallek; Wolfgang Hiddemann; Hans-Jochem Kolb
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.
Blood 2006;108(3):1092-9.
2006: Verena Pihusch; Andreas Rank; Ruth Steber; Markus Pihusch; Rudolf Pihusch; Bettina Toth; Erhard Hiller; Hans-Jochem Kolb
Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients.
Transplantation 2006;81(10):1405-9.
2006: Martin Weisser; Johanna Tischer; Susanne Schnittger; Claudia Schoch; Georg Ledderose; Hans-Jochem Kolb
A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.
Haematologica 2006;91(5):663-6.
2006: Alois Gratwohl; Ronald Brand; Jane Apperley; Charles Crawley; Tapani Ruutu; Paolo Corradini; Enric Carreras; Agnès Devergie; cesare guglielmi; Hans-Jochem Kolb; Dietger Niederwieser
Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Haematologica 2006;91(4):513-21.
2006: Ole Maywald; Markus Pfirrmann; Ute Berger; Lusine Breitscheidel; Alois Gratwohl; Hans-Jochem Kolb; D W Beelen; Andreas Tobler; Georgia Metzgeroth; S U Gnad; Andreas Hochhaus; Joerg Hasford; Rüdiger Hehlmann; Andreas Reiter
Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia.
Leukemia 2006;20(3):477-84.
2006: Markus Pihusch; Rudolf Pihusch; Peter Fraunberger; Verena Pihusch; Reinhard Andreesen; Hans-Jochem Kolb; Ernst Holler
Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.
European journal of haematology 2006;76(2):93-101.
2006: Thomas Duell; Brigitte Poleck-Dehlin; Christoph Schmid; Bettina Wunderlich; Georg Ledderose; Johann Mittermuller; Hans-Jochem Kolb; Helga Schmetzer
Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia.
Acta haematologica 2006;116(2):131-6.
2006: Christina Rieger; Andreas Rank; Michael Fiegl; Johanna Tischer; Xaver Schiel; Helmut Ostermann; Hans-Jochem Kolb
Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier Syndrome.
Thrombosis and haemostasis 2006;95(1):190-1.
2006: Stefan Boeck; M Hamann; Verena Pihusch; T Heller; Heinz Diem; Burkhard Rolf; Rudolf Pihusch; Hans-Jochem Kolb; Markus Pihusch
Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
Bone marrow transplantation 2006;37(1):57-64.
2005: Malek Aoudjhane; Myriam Labopin; Norbert-Claude Gorin; Avichai Shimoni; T Ruutu; Hans-Jochem Kolb; Francesco Frassoni; Jean-Michel Boiron; J L Yin; J Finke; H Shouten; Didier Blaise; Michele Falda; A A Fauser; J Esteve; Emmanuelle Polge; S Slavin; Dietger Niederwieser; Arnon Nagler; Vanderson Rocha
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).
Leukemia 2005;19(12):2304-12.
2005: Markus Pihusch; Holger Wegner; Peter Goehring; Christoph Salat; Verena Pihusch; Erhard Hiller; Reinhard Andreesen; Hans-Jochem Kolb; Ernst Holler; Rudolf Pihusch
Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients.
Transplantation 2005;80(10):1376-82.
2005: Hans-Joachim Stemmler; H Menzel; Christoph Salat; Horst Lindhofer; Steffen Kahlert; Volker Heinemann; Hans-Jochem Kolb
Lasting remission following multimodal treatment in a patient with metastatic breast cancer.
Anti-cancer drugs 2005;16(10):1135-7.
2005: Michael Fiegl; Armin Gerbitz; Antonia Gaeta; Hartmut Campe; Gundula Jaeger; Hans-Jochem Kolb
Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: the role of immunosuppression.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34(3):219-23.
2005: Markus Pihusch; Holger Wegner; P Goehring; Christoph Salat; Verena Pihusch; Reinhard Andreesen; Hans-Jochem Kolb; Ernst Holler; Rudolf Pihusch
Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2005;36(7):631-7.
2005: Markus Pihusch; Stefan Boeck; Moritz Hamann; Verena Pihusch; Tatjana Heller; Heinz Diem; Burkhard Rolf; Rudolf Pihusch; Reinhard Andreesen; Ernst Holler; Hans-Jochem Kolb
Peripheral dendritic cell chimerism in allogeneic hematopoietic stem cell recipients.
Transplantation 2005;80(6):843-9.
2005: Christoph Schmid; Michael Schleuning; Georg Ledderose; Johanna Tischer; Hans-Jochem Kolb
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5675-87.
2005: Leticia G León; Luciana K Ostronoff; María Luisa Fermín; Cristina Fragío; Elisabeth Kremmer; Hans-Jochem Kolb; Concepción Tejero
In vitro generation of mature neutrophils from canine Lin- bone marrow cells.
Veterinary immunology and immunopathology 2005;107(1-2):41-50.
2005: S Kufner; Horst Zitzelsberger; T Kroell; Renate Pelka-Fleischer; A Salem; F de Valle; Claudia Schweiger; Volkmar Nuessler; C Schmid; Hans-Jochem Kolb; Helga Schmetzer
Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Scandinavian journal of immunology 2005;62(1):86-98.
2005: S Kufner; Horst Zitzelsberger; T Kroell; Renate Pelka-Fleischer; A Salem; F de Valle; C Schmid; Claudia Schweiger; Hans-Jochem Kolb; Helga Schmetzer
Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
Scandinavian journal of immunology 2005;62(1):75-85.
2005: Hans-Joachim Stemmler; Christoph Salat; Horst Lindhofer; H Menzel; Michael Untch; Steffen Kahlert; Gottfried E Konecny; Hansjörg Sauer; Georg Ledderose; Volker Heinemann; Hans-Jochem Kolb
Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
Anticancer research 2005;25(4):3047-54.
2005: Martina Wiesner; Caroline Zentz; Markus H Hammer; Mark Cobbold; Florian Kern; Hans-Jochem Kolb; Wolfgang Hammerschmidt; Reinhard Zeidler; Andreas Moosmann
Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.
European journal of immunology 2005;35(7):2110-21.
2005: Ute Berger; Ole Maywald; Markus Pfirrmann; Tanja Lahaye; Andreas Hochhaus; Andreas Reiter; Joerg Hasford; Hermann Heimpel; Dieter K Hossfeld; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Rüdiger Hehlmann
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies.
Leukemia 2005;19(6):984-9.
2005: Andreas Reiter; Christoph Walz; Ann Watmore; Claudia Schoch; Ilona Blau; Brigitte Schlegelberger; Ute Berger; Nick Telford; Shilani Aruliah; John A Yin; Danny Vanstraelen; Helen F Barker; Peter C Taylor; Aisling O'Driscoll; Fabio Benedetti; Cornelia Rudolph; Hans-Jochem Kolb; Andreas Hochhaus; Rüdiger Hehlmann; Andrew Chase; Nicholas C P Cross
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
Cancer research 2005;65(7):2662-7.
2005: Hakumei Oh; Fausto R Loberiza; Mei-Jie Zhang; Olle Ringdén; Hideki Akiyama; Takayoshi Asai; Shuichi Miyawaki; Shinichiro Okamoto; Mary M Horowitz; Joseph H Antin; Asad Bashey; Jennifer M Bird; Matthew H Carabasi; Joseph W Fay; Robert Peter Gale; Roger H Giller; John M Goldman; gregory alan hale; Richard E Harris; Jean Henslee-Downey; Hans-Jochem Kolb; Mark R Litzow; Philip L McCarthy; Steven M Neudorf; Derek S Serna; Gérard Socié; Pierre Tiberghien; A John Barrett
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
Blood 2005;105(4):1408-16.
2005: Hans-Jochem Kolb; Christoph Schmid; Raymund Buhmann; Johanna Tischer; Georg Ledderose
DLI: where are we know?
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():115-6.
2005: Verena Pihusch; Markus Pihusch; Marius Penovici; Hans-Jochem Kolb; Erhard Hiller; Rudolf Pihusch
Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
Thrombosis research 2005;116(3):233-40.
2005: Marcus Hentrich; Daniel Oruzio; Gabriele Jäger; Marcus Schlemmer; Michael Schleuning; Xaver Schiel; Wolfgang Hiddemann; Hans-Jochem Kolb
Impact of human herpesvirus-6 after haematopoietic stem cell transplantation.
British journal of haematology 2005;128(1):66-72.
2004: Martin Weisser; Michael Schleuning; Georg Ledderose; Burkhard Rolf; Susanne Schnittger; Claudia Schoch; Rainer Schwerdtfeger; Hans-Jochem Kolb
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.
Bone marrow transplantation 2004;34(12):1083-8.
2004: Markus Pihusch; Peter Lohse; Jill Reitberger; Erhard Hiller; Reinhard Andreesen; Hans-Jochem Kolb; Ernst Holler; Rudolf Pihusch
Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(6):911-8.
2004: Hans-Jochem Kolb; Andreas Rank; Xiao Chen; Anja Woiciechowsky; Marie Roskrow; Christoph Schmid; Johanna Tischer; Georg Ledderose
In-vivo generation of leukaemia-derived dendritic cells.
Best practice & research. Clinical haematology 2004;17(3):439-51.
2004: C Scheinkönig; S Kappicht; Hans-Jochem Kolb; Michael Schleuning
Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells.
Bone marrow transplantation 2004;34(6):531-6.
2004: Raymond Voltz; Michaela Starck; Vera Zingler; Michael Strupp; Hans-Jochem Kolb
Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):472-4.
2004: C Schmid; Michael Schleuning; J Aschan; O Ringdén; J Hahn; Ernst Holler; U Hegenbart; Dietger Niederwieser; M Dugas; Georg Ledderose; Hans-Jochem Kolb
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.
Leukemia 2004;18(8):1430-3.
2004: Thorsten Kaiser; Haytham Kamal; Andreas Rank; Hans-Jochem Kolb; Ernst Holler; Arnold Ganser; Bernd Hertenstein; Mischak Harald; Eva M Weissinger
Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(2):340-9.
2004: Eva M Weissinger; K Oettrich; C Evans; Hans-Gottfried Genieser; Frank Schwede; Marc Dangers; Elke Dammann; Hans-Jochem Kolb; Mischak Harald; Arnold Ganser; Walter Kolch
Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy.
British journal of cancer 2004;91(1):186-92.
2004: Andreas Hoeflich; Lutz Bünger; Sabine Nedbal; Ulla Renne; Martin W Elmlinger; Werner F Blum; Charlotte Bruley; Hans-Jochem Kolb; Eckhard Wolf
Growth selection in mice reveals conserved and redundant expression patterns of the insulin-like growth factor system.
General and comparative endocrinology 2004;136(2):248-59.
2004: Hans-Jochem Kolb; Belinda Simoes; Christoph Schmid
Cellular immunotherapy after allogeneic stem cell transplantation in hematologic malignancies.
Current opinion in oncology 2004;16(2):167-73.
2004: Hans-Jochem Kolb; Christoph Schmid; A John Barrett; Dolores Schendel
Graft-versus-leukemia reactions in allogeneic chimeras.
Blood 2004;103(3):767-76.
2004: M L Fermín; S Gaitán; Cristina Fragío; L G Léon; L K Ostronoff; Elisabeth Kremmer; Hans-Jochem Kolb; Concepción Tejero
Canine long-term bone marrow culture neutrophil production and functionality.
Acta haematologica 2004;111(4):196-204.
2004: Michael Schleuning; Harald Buxbaum-Conradi; Gabriele Jäger; Hans-Jochem Kolb
Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):135-44.
2003: Andreas Hoeflich; O Fettscher; G Preta; Harald Lahm; Hans-Jochem Kolb; Eckhard Wolf; Matthias M Weber
Increased activity of catalase in tumor cells overexpressing IGFBP-2.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(11-12):816-21.
2003: Ulrich Wahl; Elfriede Nössner; Konrad Kronenberger; Rainer Gangnus; Heike Pohla; Martin Staege; Hans-Jochem Kolb; Michael Hallek; Ralph Mocikat
Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: preclinical evaluation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4240-6.
2003: Ute Berger; Georg Engelich; Ole Maywald; Markus Pfirrmann; Andreas Hochhaus; Andreas Reiter; Georgia Metzgeroth; U Gnad; Joerg Hasford; Barbara Heinze; Hermann Heimpel; Dieter K Hossfeld; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Rüdiger Hehlmann
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha.
Leukemia 2003;17(9):1820-6.
2003: Iris Bittmann; Marcus Hentrich; Karl Bise; Hans-Jochem Kolb; Udo Löhrs
Endothelial cells but not epithelial cells or cardiomyocytes are partially replaced by donor cells after allogeneic bone marrow and stem cell transplantation.
Journal of hematotherapy & stem cell research 2003;12(4):359-66.
2003: Axel R Zander; Nicolaus Kröger; Michael Schleuning; J Finke; Tatjana Zabelina; Dietrich W Beelen; Rainer Schwerdtfeger; H Baurmann; Martin Bornhäuser; Gerhard Ehninger; Axel A Fauser; Michael Kiehl; Rudolf Trenschel; Hellmut D Ottinger; H Bertz; J Berger; Hans-Jochem Kolb; Ulrich W Schaefer
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone marrow transplantation 2003;32(4):355-61.
2003: Michael Schleuning; W Günther; Johanna Tischer; Georg Ledderose; Hans-Jochem Kolb
Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
Bone marrow transplantation 2003;32(3):243-50.
2003: Martin Weber; Claudia Lange; Wolfgang Günther; Monika Franz; Elisabeth Kremmer; Hans-Jochem Kolb
Minor histocompatibility antigens on canine hemopoietic progenitor cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(12):5861-8.
2003: Wolfgang Kern; Susanne Danhauser-Riedl; Richard Ratei; Susanne Schnittger; Claudia Schoch; Hans-Jochem Kolb; Wolf-Dieter Ludwig; Wolfgang Hiddemann; Torsten Haferlach
Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
Haematologica 2003;88(6):646-53.
2003: Hans-Jochem Kolb; Wolfgang Guenther; Boglarka Gyurkocza; Florian Hoetzl; Belinda Simoes; Christine Falk; Michael Schleuning; Georg Ledderose
Tolerance and chimerism.
Transplantation 2003;75(9 Suppl):26S-31S.
2003: Petra Sostak; Claudio S Padovan; Tarek A Yousry; Georg Ledderose; Hans-Jochem Kolb; Andreas Straube
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.
Neurology 2003;60(5):842-8.
2003: Claudio S Padovan; Petra Sostak; Petra Reich; Hans-Jochem Kolb; Wolfgang Müller-Felber; Andreas Straube
[Neuromuscular complications after allogeneic bone marrow transplantation].
Der Nervenarzt 2003;74(2):159-66.
2003: Hans-Jochem Kolb; Christoph Schmid; Xiao Chen; Anja Woiciechowski; Marie Roskrow; Martin Weber; Wolfgang Guenther; Georg Ledderose; Michael Schleuning
Adoptive immunotherapy in chimeras with donor lymphocytes.
Acta haematologica 2003;110(2-3):110-20.
2002: Alois Gratwohl; Ronald Brand; Jane Apperley; Anja v Biezen Av; Giuseppe Bandini; Agnès Devergie; Anton Schattenberg; Francesco Frassoni; cesare guglielmi; Simona Iacobelli; Mauricette Michallet; Hans-Jochem Kolb; Tapani Ruutu; Dietger Niederwieser
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.
Blood 2002;100(12):3877-86.
2002: Rudolf Pihusch; Christoph Salat; Edwin Schmidt; Peter Göhring; Markus Pihusch; Erhard Hiller; Ernst Holler; Hans-Jochem Kolb
Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.
Transplantation 2002;74(9):1303-9.
2002: C Schmid; Martin Weisser; Georg Ledderose; OJ Stötzer; Michael Schleuning; Hans-Jochem Kolb
[Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
Deutsche medizinische Wochenschrift (1946) 2002;127(42):2186-92.
2002: Rudolf Pihusch; Holger Wegner; Christoph Salat; Markus Pihusch; Ernst Holler; Hans-Jochem Kolb; Erhard Hiller
Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2002;30(6):381-7.
2002: Rudolf Pihusch; Ernst Holler; Dieter Mühlbayer; Peter Göhring; OJ Stötzer; Markus Pihusch; Erhard Hiller; Hans-Jochem Kolb
The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation.
Bone marrow transplantation 2002;30(6):347-54.
2002: Rudolf Pihusch; B Höhnberg; Christoph Salat; Markus Pihusch; Erhard Hiller; Hans-Jochem Kolb
Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation.
Annals of hematology 2002;81(8):454-61.
2002: cesare guglielmi; William Arcese; Francesco Dazzi; Ronald Brand; Donald Bunjes; Leo F Verdonck; Anton Schattenberg; Hans-Jochem Kolb; Per Ljungman; Agnès Devergie; Andrea Bacigalupo; Marta Gomez; Mauricette Michallet; Ahmet H Elmaagacli; Alois Gratwohl; Jane Apperley; Dietger Niederwieser
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose.
Blood 2002;100(2):397-405.
2002: Rudolf Pihusch; Christoph Salat; Peter Göhring; Marcus Hentrich; Holger Wegner; Markus Pihusch; Erhard Hiller; Hans-Jochem Kolb; Helmut Ostermann
Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut.
British journal of haematology 2002;117(2):469-76.
2002: Hans-Jochem Kolb; Ch Schmid; Martin Weisser; Markus Pihusch; Johanna Tischer; Rudolf Pihusch; Oliver J Stoetzer; Georg Ledderose; Michael Schleuning
Cytoreduction, DLI, or mobilized peripheral blood progenitors.
Annals of hematology 2002;81 Suppl 2():S30-3.
2002: Heike Fiegler; Michael Knabel; Monika Franz; Hans-Jochem Kolb; Ursula Just
Determination of donor-type chimerism using a semi-quantitative PCR-based method in a canine model for bone marrow transplantation.
Veterinary immunology and immunopathology 2002;84(1-2):61-70.
2002: Michael Schleuning; Oliver J Stoetzer; Christine Waterhouse; Marcus Schlemmer; Georg Ledderose; Hans-Jochem Kolb
Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease.
Experimental hematology 2002;30(1):7-10.
2001: Andreas Hoeflich; R Reisinger; Harald Lahm; Wieland Kiess; Werner F Blum; Hans-Jochem Kolb; Matthias M Weber; Eckhard Wolf
Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?
Cancer research 2001;61(24):8601-10.
2001: Hans-Jochem Kolb; E Mischak-Weissinger
[Cell therapy of hematological neoplasms].
Der Internist 2001;42(10):1374-83.
2001: OJ Stötzer; Michael Schleuning; Georg Ledderose; Wolfgang Hiddemann; Hans-Jochem Kolb
[Allogeneic transplantation in malignant lymphoma].
Deutsche medizinische Wochenschrift (1946) 2001;126(39):1062-9.
2001: U Schulz; Reinhold Munker; B Ertl; Ernst Holler; Hans-Jochem Kolb
Different types of human leukemias express the message for TNF-alpha and interleukin-10.
European journal of medical research 2001;6(8):359-63.
2001: Andreas Hoeflich; Sabine Nedbal; Werner F Blum; M Erhard; Harald Lahm; G Brem; Hans-Jochem Kolb; Rüdiger Wanke; Eckhard Wolf
Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2.
Endocrinology 2001;142(5):1889-98.
2001: Reinhold Munker; Christoph Salat; Rudolf Pihusch; Heinz Diem; Erhard Hiller; J Glass; Hans-Jochem Kolb; H Yu
Levels of insulin-like growth factor after stem cell transplantation.
European journal of medical research 2001;6(4):181-4.
2001: Anja Woiciechowsky; S Regn; Hans-Jochem Kolb; Marie Roskrow
Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia.
Leukemia 2001;15(2):246-55.
2001: S Regn; Silke Raffegerst; Xiao Chen; Dolores Schendel; Hans-Jochem Kolb; Marie Roskrow
Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant.
Bone marrow transplantation 2001;27(1):53-64.
2000: Xiao Chen; Anja Woiciechowsky; Silke Raffegerst; Dolores Schendel; Hans-Jochem Kolb; Marie Roskrow
Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis.
British journal of haematology 2000;111(3):817-25.
2000: Xiao Chen; S Regn; Silke Raffegerst; Hans-Jochem Kolb; Marie Roskrow
Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia.
British journal of haematology 2000;111(2):596-607.
2000: Ralf Huss; Eva M Weissinger; C Lange; P Gatsios; Günther Eissner; Hans-Jochem Kolb; Joachim Diebold; Peter C Heinrich; Lutz Graeve
In vitro-generated stem cell leukaemia showing altered cell cycle progression with distinct signalling of the tyrosine-phosphorylated rasGAP-associated p62(dok) protein.
The Journal of pathology 2000;192(3):363-72.
2000: Hellmut D Ottinger; C Müller; Norbert Schmitz; B Kubanek; Renate Arnold; Wolfram Ebell; H P Eberhard; Gerhard Ehninger; U Fronz; Shraga F Goldmann; Hans Grosse-Wilde; Werner Havers; Thomas Klingebiel; Hans-Jochem Kolb; Siegfried Seeber; Ulrich W Schaefer; H Baldomero; Alois Gratwohl
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation.
Annals of hematology 2000;79(8):437-43.
2000: Ralf Huss; P Gatsios; Lutz Graeve; C Lange; Günther Eissner; Hans-Jochem Kolb; K Thalmeier; Peter C Heinrich
Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation.
Cytokine 2000;12(8):1195-204.
2000: cesare guglielmi; William Arcese; J Hermans; A Bacigalupo; Giuseppe Bandini; Donald Bunjes; E Carreras; Agnès Devergie; F Frassoni; J Goldman; A Gratwohl; Hans-Jochem Kolb; Anna Paola Iori; Dietger Niederwieser; H G Prentice; T de Witte; Jane Apperley
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2000;95(11):3328-34.
2000: Andreas Hoeflich; O Fettscher; Harald Lahm; Werner F Blum; Hans-Jochem Kolb; Dieter Engelhardt; Eckhard Wolf; Matthias M Weber
Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells.
Cancer research 2000;60(4):834-8.
2000: Ernst Holler; M G Roncarolo; R Hintermeier-Knabe; Günther Eissner; B Ertl; U Schulz; H Knabe; Hans-Jochem Kolb; Reinhard Andreesen; W Wilmanns
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation.
Bone marrow transplantation 2000;25(3):237-41.
2000: Ralf Huss; C Lange; Eva M Weissinger; Hans-Jochem Kolb; K Thalmeier
Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics.
Stem cells (Dayton, Ohio) 2000;18(4):252-60.
1999: Andreas Hoeflich; M Wu; Subburaman Mohan; J Föll; Rüdiger Wanke; Thomas Fröhlich; Georg J Arnold; Harald Lahm; Hans-Jochem Kolb; Eckhard Wolf
Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain.
Endocrinology 1999;140(12):5488-96.
1999: Rüdiger Hehlmann; Andreas Hochhaus; Hans-Jochem Kolb; Joerg Hasford; Alois Gratwohl; Hermann Heimpel; Wolfgang Siegert; J Finke; Gerhard Ehninger; E Holler; Ute Berger; Markus Pfirrmann; A Muth; Axel Zander; A A Fauser; A Heyll; Christoph Nerl; Dieter K Hossfeld; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Tobler
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
Blood 1999;94(11):3668-77.
1999: Hans-Jochem Kolb; G Socié; Thomas Duell; MT van Lint; A Tichelli; JF Apperley; Elke A Nekolla; P Ljungman; N Jacobsen; M van Weel; R Wick; M Weiss; H G Prentice
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
Annals of internal medicine 1999;131(10):738-44.
1999: C Lange; C Kaltz; K Thalmeier; Hans-Jochem Kolb; Ralf Huss
Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1(low), c-kit+ stem cell line.
Journal of hematotherapy & stem cell research 1999;8(4):335-42.
1999: Claudio S Padovan; Karl Bise; J Hahn; Petra Sostak; Ernst Holler; Hans-Jochem Kolb; Andreas Straube
Angiitis of the central nervous system after allogeneic bone marrow transplantation?
Stroke; a journal of cerebral circulation 1999;30(8):1651-6.
1999: M Brandl; L Grosse-Hovest; Ernst Holler; Hans-Jochem Kolb; Gundram Jung
Bispecific antibody fragments with CD20 X CD28 specificity allow effective autologous and allogeneic T-cell activation against malignant cells in peripheral blood and bone marrow cultures from patients with B-cell lineage leukemia and lymphoma.
Experimental hematology 1999;27(8):1264-70.
1999: Thomas Bosch; Raymund Buhmann; Andrea Lennertz; Walter Samtleben; Hans-Jochem Kolb
Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 1999;3(3):252-6.
1999: Gérard Socié; JV Stone; J R Wingard; Daniel Weisdorf; PJ Henslee-Downey; Christopher N Bredeson; J Y Cahn; Jakob R Passweg; Philip Rowlings; H C Schouten; Hans-Jochem Kolb; John P Klein
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
The New England journal of medicine 1999;341(1):14-21.
1999: Amnon Cohen; Attilio Rovelli; B Bakker; Cornelio Uderzo; MT van Lint; H Esperou; Alberto Gaiero; A D Leiper; R Dopfer; J Y Cahn; F Merlo; Hans-Jochem Kolb; G Socié
Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT.
Blood 1999;93(12):4109-15.
1999: Christoph Salat; Ernst Holler; Erhard Hiller; Rudolf Pihusch; Hans-Jochem Kolb
Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.
Haematologica 1999;84 Suppl EHA-4():40-3.
1999: Amnon Cohen; Thomas Duell; G Socié; MT van Lint; M Weiss; A Tichelli; Attilio Rovelli; JF Apperley; P Ljungman; Hans-Jochem Kolb
Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1999;23(10):1043-7.
1999: Michael Schleuning; Gabriele Jäger; Ernst Holler; W Hill; C Thomssen; Claudio Denzlinger; T Lorenz; Georg Ledderose; W Wilmanns; Hans-Jochem Kolb
Human parvovirus B19-associated disease in bone marrow transplantation.
Infection 1999;27(2):114-7.
1999: Clemens-Martin Wendtner; Raymund Buhmann; Hans-Jochem Kolb; Bertold Emmerich; Michael Hallek
[Recurring vertigo and syncope in a patient with eosinophilia].
Der Internist 1999;40(3):305-10.
1999: Christoph Salat; Ernst Holler; Hans-Jochem Kolb; Rudolf Pihusch; B Reinhardt; Marius Penovici; Georg Ledderose; Erhard Hiller
The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation.
Leukemia & lymphoma 1999;33(1-2):25-32.
1999: Michael Schleuning; J Mittermüller; Hans-Jochem Kolb
Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patients.
European journal of haematology 1999;62(3):149-54.
1998: Peter Neumeister; Erhard Hiller; M Gawaz; Ernst Holler; Hans-Jochem Kolb; Heinz Sill; Rudolf Pihusch; W Mempel; G Wittmann; Christoph Salat
Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot study.
European journal of medical research 1998;3(10):465-9.
1998: MG Ismair; Christian Ries; F Lottspeich; Chuanbing Zang; Hans-Jochem Kolb; Petro E Petrides
Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1.
Leukemia 1998;12(7):1136-43.
1998: Claudio S Padovan; Tarek A Yousry; Michael Schleuning; Ernst Holler; Hans-Jochem Kolb; Andreas Straube
Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation.
Annals of neurology 1998;43(5):627-33.
1998: Andreas Hoeflich; P Schmidt; J Föll; OJ Rottmann; Matthias M Weber; Hans-Jochem Kolb; F Pirchner; Eckhard Wolf
Altered growth of mice divergently selected for body weight is associated with complex changes in the growth hormone/insulin-like growth factor system.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1998;8(2):113-23.
1998: Robert Peter Gale; R Hehlmann; Mei-Jie Zhang; Joerg Hasford; John M Goldman; Hermann Heimpel; A Hochhaus; John P Klein; Hans-Jochem Kolb; Philip B McGlave; Jakob R Passweg; Philip Rowlings; Kathleen A Sobocinski; Mary M Horowitz
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.
Blood 1998;91(5):1810-9.
1998: Volker Runde; Theo de Witte; Renate Arnold; Alois Gratwohl; J Hermans; Anja van Biezen; Dietger Niederwieser; Myriam Labopin; M P Walter-Noel; Andrea Bacigalupo; Niels Jacobsen; Per Ljungman; Enric Carreras; Hans-Jochem Kolb; C Aul; Jane Apperley
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(3):255-61.
1997: Hans-Jochem Kolb; C Poetscher
Late effects after allogeneic bone marrow transplantation.
Current opinion in hematology 1997;4(6):401-7.
1997: H Link; Hans-Jochem Kolb; Wolfram Ebell; D K Hossfeld; A Zander; D Niethammer; Hannes Wandt; H Grosse-Wilde; U W Schaefer
[Transplantation of hematopoietic stem cells. II: Indications for transplantation of hematopoietic stem cells after myeloablative therapy].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(9):534-45.
1997: H Link; Hans-Jochem Kolb; Wolfram Ebell; D K Hossfeld; A Zander; D Niethammer; Hannes Wandt; H Grosse-Wilde; U W Schaefer
[Transplantation of hematopoietic stem cells. I: Definitions, principle indications, complications].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(8):480-91, 505.
1997: Hellmut D Ottinger; E Albert; Renate Arnold; D W Beelen; R Blasczyk; D Bunjes; Stefan Burdach; Wolfram Ebell; Gerhard Ehninger; H Einsele; Jürgen Enczmann; Axel A Fauser; W Friedrich; J Finke; Ulrich Göbel; Shraga F Goldmann; M Gramatzki; Werner Helbig; L Kanz; Thomas Klingebiel; Hans-Jochem Kolb; P Kühnl; C Löliger; C R Müller; Hans Grosse-Wilde
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1997;20(2):101-5.
1997: Agnès Devergie; Jane F Apperley; Myriam Labopin; A Madrigal; Niels Jacobsen; Enric Carreras; H G Prentice; Jean-Pierre Jouet; Hans-Jochem Kolb; B Herstenstein; Andrea Bacigalupo; S A Evensen; Per Ljungman; Theo de Witte; Josy Reiffers; A Nagler; R E Clark; J M Goldman; Alois Gratwohl
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1997;20(1):11-9.
1997: Volker Heinemann; D Bosse; Ulrich Jehn; B Kähny; Kirsten Wachholz; A Debus; P Scholz; Hans-Jochem Kolb; W Wilmanns
Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.
Antimicrobial agents and chemotherapy 1997;41(6):1275-80.
1997: O Ringdén; Myriam Labopin; Eliane Gluckman; Jill M Hows; Benjamin A Bradley; Hans-Jochem Kolb; Loïc Fouillard; Niels Jacobsen; Jean-Paul Vernant; Francis Witz; Jean-Luc Harousseau; Norbert-Claude Gorin
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study.
Bone marrow transplantation 1997;19(10):963-8.
1997: R Szydlo; John M Goldman; John P Klein; Robert Peter Gale; R C Ash; F H Bach; Benjamin A Bradley; James T Casper; Neal Flomenberg; James L Gajewski; Eliane Gluckman; PJ Henslee-Downey; Jill M Hows; Niels Jacobsen; Hans-Jochem Kolb; B Lowenberg; T Masaoka; Philip Rowlings; Paul M Sondel; D W van Bekkum; Jon van Rood; MR Vowels; Mei-Jie Zhang; Mary M Horowitz
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1767-77.
1997: Christoph Salat; Ernst Holler; Hans-Jochem Kolb; Rudolf Pihusch; B Reinhardt; Erhard Hiller
Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
Bone marrow transplantation 1997;19(9):909-14.
1997: Rüdiger Hehlmann; Andreas Willer; Hermann Heimpel; Joerg Hasford; Hans-Jochem Kolb; Hans Pralle; Dieter K Hossfeld; Wolfgang Queisser; Helmut Löffler; Andreas Hochhaus; Andreas Tobler; Eva Lengfelder; Ute Berger; Christine Leib-Mösch
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group.
Leukemia 1997;11 Suppl 3():506-11.
1997: Ernst Holler; B Ertl; R Hintermeier-Knabe; M G Roncarolo; Günther Eissner; F Mayer; Peter Fraunberger; U Behrends; W Pfannes; Hans-Jochem Kolb; W Wilmanns
Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation?
Leukemia & lymphoma 1997;25(3-4):217-24.
1997: Rüdiger Hehlmann; H Ansari; Joerg Hasford; Hermann Heimpel; Dieter K Hossfeld; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Reiter; Andreas Hochhaus
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study Group.
British journal of haematology 1997;97(1):76-85.
1997: Thomas Duell; J Mittermüller; Helga Schmetzer; Hans-Jochem Kolb; W Wilmanns
Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32).
Cancer genetics and cytogenetics 1997;94(2):91-4.
1997: Volker Heinemann; B Kähny; Ulrich Jehn; Dieter Mühlbayer; A Debus; Kirsten Wachholz; D Bosse; Hans-Jochem Kolb; W Wilmanns
Serum pharmacology of amphotericin B applied in lipid emulsions.
Antimicrobial agents and chemotherapy 1997;41(4):728-32.
1997: Christoph Salat; Ernst Holler; Hans-Jochem Kolb; B Reinhardt; Rudolf Pihusch; W Wilmanns; Erhard Hiller
Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation.
Blood 1997;89(6):2184-8.
1997: Hans-Jochem Kolb; Ernst Holler
Adoptive immunotherapy with donor lymphocyte transfusions.
Current opinion in oncology 1997;9(2):139-45.
1997: Christoph Salat; Ernst Holler; C Wolf; Hans-Jochem Kolb; B Reinhardt; Rudolf Pihusch; HJ Krämling; Volker Heinemann; M Haller; Erhard Hiller
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Bone marrow transplantation 1997;19(5):487-90.
1997: V Nüssler; Frank Gieseler; Heinz Zwierzina; E Gullis; Renate Pelka-Fleischer; H Diem; W Abenhardt; R Schmitt; I Langenmayer; A Wohlrab; Hans-Jochem Kolb; W Wilmanns
Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression.
Annals of hematology 1997;74(2):57-64.
1997: Thomas Duell; MT van Lint; P Ljungman; A Tichelli; G Socié; JF Apperley; M Weiss; A Cohen; Elke A Nekolla; Hans-Jochem Kolb
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.
Annals of internal medicine 1997;126(3):184-92.
1997: Wolfgang Hinterberger; Philip Rowlings; Margareta Hinterberger-Fischer; J Gibson; Niels Jacobsen; John P Klein; Hans-Jochem Kolb; D A Stevens; Mary M Horowitz; Robert Peter Gale
Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia.
Annals of internal medicine 1997;126(2):116-22.
1997: Hans-Jochem Kolb; Ernst Holler
Hematopoietic transplantation: state of the art.
Stem cells (Dayton, Ohio) 1997;15 Suppl 1():151-7; discussion 158.
1996: Christoph Salat; Ernst Holler; P Göhring; S Poley; Hans-Jochem Kolb; Rudolf Pihusch; B Reinhardt; HJ Krämling; M Haller; Erhard Hiller
Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
European journal of medical research 1996;1(12):571-4.
1996: Andreas Hoeflich; Y Yang; S Huber; Wolfgang Rascher; G Koepf; Werner F Blum; P Heinz-Erian; Hans-Jochem Kolb; Wieland Kiess
Expression of IGFBP-2, -3, and -4 mRNA during differentiation of Caco-2 colon epithelial cells.
The American journal of physiology 1996;271(5 Pt 1):E922-31.
1996: Andreas Hoeflich; Y Yang; Wolfgang Rascher; Werner F Blum; S Huber; G Koepf; Hans-Jochem Kolb; Wieland Kiess
Coordinate expression of insulin-like growth factor II (IGF-II) and IGF-II/mannose-6-phosphate receptor mRNA and stable expression of IGF-I receptor mRNA during differentiation of human colon carcinoma cells (Caco-2).
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(1):49-59.
1996: André Tichelli; Thomas Duell; M Weiss; G Socié; P Ljungman; Amnon Cohen; MT van Lint; Alois Gratwohl; Hans-Jochem Kolb
Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
Bone marrow transplantation 1996;17(6):1105-11.
1996: Rüdiger Hehlmann; Hermann Heimpel; Dieter K Hossfeld; Joerg Hasford; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Hochhaus; A Tichelli; W Fett; Norbert Schmitz; A Reiter; Martin Griesshammer; W Pfeifer; M Bümler; T Kamp; Andreas Tobler; Hartmut Eimermacher; R Kuse; Ute Berger; H Ansari
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Bone marrow transplantation 1996;17 Suppl 3():S21-4.
1996: Hans-Jochem Kolb; J Mittermüller; Ernst Holler; K Thalmeier; C R Bartram
Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia.
Bone marrow transplantation 1996;17(3):449-52.
1996: C Botzler; Hans-Jochem Kolb; Rolf Issels; Gabriele Multhoff
Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells.
International journal of cancer. Journal international du cancer 1996;65(5):633-8.
1995: Daniel Stachel; Irene Schmid; Christian Straka; R Handgretinger; Hans-Jochem Kolb; R J Haas
Allogenic peripheral blood stem cell (PBSC) transplantation in two patients with graft failure.
Bone marrow transplantation 1995;16(6):839-42.
1995: Hans-Jochem Kolb; A Schattenberg; J M Goldman; B Hertenstein; N Jacobsen; W Arcese; P Ljungman; A Ferrant; L Verdonck; Dietger Niederwieser; F van Rhee; J Mittermueller; T de Witte; Ernst Holler; H Ansari
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.
Blood 1995;86(5):2041-50.
1995: Ernst Holler; Hans-Jochem Kolb; J Mittermüller; M Kaul; Georg Ledderose; Thomas Duell; B Seeber; Michael Schleuning; R Hintermeier-Knabe; B Ertl
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F).
Blood 1995;86(3):890-9.
1994: Rüdiger Hehlmann; Hermann Heimpel; Joerg Hasford; Hans-Jochem Kolb; Hans Pralle; Dieter K Hossfeld; Wolfgang Queisser; Helmut Löffler; Andreas Hochhaus; Barbara Heinze
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
Blood 1994;84(12):4064-77.
1994: Christoph Salat; Ernst Holler; B Reinhardt; Hans-Jochem Kolb; B Seeber; Georg Ledderose; J Mittermueller; Thomas Duell; W Wilmanns; Erhard Hiller
Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease.
Bone marrow transplantation 1994;14(5):747-50.
1994: Michael Schleuning; C Thomssen; Hans-Jochem Kolb; H J Sauer; W Wilmanns
Treatment of refractory severe aplastic anemia with granulocyte colony stimulating factor and interleukin 3.
American journal of hematology 1994;46(3):250-1.
1994: Christoph Salat; Ernst Holler; B Reinhardt; Hans-Jochem Kolb; Rudolf Pihusch; Peter Neumeister; Erhard Hiller
[Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation].
Medizinische Klinik (Munich, Germany : 1983) 1994;89(5):245-7.
1994: Rüdiger Hehlmann; P Kister; Andreas Willer; M Simon; M Schenk; Wolfgang Seifarth; G Papakonstantinou; Susanne Saussele; Hans-Jochem Kolb; H Ansari
Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group.
Leukemia 1994;8 Suppl 1():S127-32.
1994: W Guenther; M Schumm; M Buettner; C Voss; E Kremmer; S Thierfelder; W Wilmanns; Hans-Jochem Kolb
NK activity of canine blood and marrow cells.
Tissue antigens 1994;43(3):198-201.
1994: C Voss; Elisabeth Kremmer; M Schumm; W Günther; G Hoffmann-Fezer; Hans-Jochem Kolb; S Thierfelder
Rat monoclonal antibodies against three different epitopes of the canine Thy-1 and their depletion capacity in vivo.
Tissue antigens 1994;43(3):193-7.
1994: M Schumm; W Günther; Hans-Jochem Kolb; P Rieber; M Büttner; C Voss; E Kremmer; P Reitmeier; S Thierfelder; W Wilmanns
Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation.
Tissue antigens 1994;43(3):170-8.
1993: Michael Schleuning; C Thomssen; Hans-Jochem Kolb; H Sauer; W Wilmanns
[61-year-old patient with hemorrhagic diathesis and fatigue].
Der Internist 1993;34(12):1141-5.
1993: C Voss; E Kremmer; G Hoffmann-Fezer; M Schumm; W Günther; Hans-Jochem Kolb; S Thierfelder
Identification and characterization of a mouse monoclonal antibody (M10) directed against canine (dog) CD8+ lymphocytes.
Veterinary immunology and immunopathology 1993;38(3-4):311-25.
1993: Rüdiger Hehlmann; Hermann Heimpel; Joerg Hasford; Hans-Jochem Kolb; Hans Pralle; Dieter K Hossfeld; Wolfgang Queisser; Helmut Löffler; Barbara Heinze; A Georgii
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.
Blood 1993;82(2):398-407.
1993: Hans-Jochem Kolb; J Mittermüller; H Hertenstein; M Schumm; Ernst Holler; T de Witte; W Günther; P Ljungman; J M Goldman
Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party.
Seminars in hematology 1993;30(3 Suppl 3):37-9.
1993: M Büttner; M Schumm; B Boenisch; E Peter Rieber; Hans-Jochem Kolb
Spontaneous tumor cell cytotoxicity mediated by peripheral blood mononuclear leukocytes of the dog.
Natural immunity 1993;12(2):92-103.
1993: Ernst Holler; Hans-Jochem Kolb; R Hintermeier-Knabe; J Mittermüller; S Thierfelder; M Kaul; W Wilmanns
Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
Transplantation proceedings 1993;25(1 Pt 2):1234-6.
1993: Rüdiger Hehlmann; Hermann Heimpel; Hans-Jochem Kolb; Barbara Heinze; Andreas Hochhaus; Martin Griesshammer; Hans Pralle; Wolfgang Queisser; U Essers; C Falge
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
Leukemia & lymphoma 1993;11 Suppl 1():159-68.
1993: Ernst Holler; Hans-Jochem Kolb; W Wilmanns
Treatment of GVHD--TNF-antibodies and related antagonists.
Bone marrow transplantation 1993;12 Suppl 3():S29-31.
1993: Hans-Jochem Kolb; J Mittermüller; W Günther; C Bartram; K Thalmaier; M Schumm; Ernst Holler; G Lederose
Adoptive immunotherapy in human and canine chimeras.
Bone marrow transplantation 1993;12 Suppl 3():S61-4.
1992: C Hötzl; C Clemm; Hans-Jochem Kolb; R Bartl; J Mittermüller; F Keil; W Wilmanns
[53-year-old patient with plethora, colic and dark urine].
Der Internist 1992;33(7):509-12.
1992: C Seeber; Erhard Hiller; Ernst Holler; Hans-Jochem Kolb
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT).
Thrombosis research 1992;66(4):373-83.
1992: Rüdiger Hehlmann; Hermann Heimpel; Martin Griesshammer; Hans-Jochem Kolb; Barbara Heinze; Dieter K Hossfeld; P D Wickramanayake; U Essers; J Thiele; A Georgii
Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group.
Leukemia 1992;6 Suppl 3():110S-114S.
1992: Hans-Jochem Kolb; W Guenther; Thomas Duell; G Socie; E Schaeffer; Ernst Holler; M Schumm; M M Horowitz; R P Gale; T M Fliedner
Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects.
Bone marrow transplantation 1992;10 Suppl 1():135-8.
1992: M Schumm; Hans-Jochem Kolb; J Hahn; K Beisser; P Rieber; W Günther; M Büttner; W Wilmanns; S Thierfelder
Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
Progress in clinical and biological research 1992;377():419-25.
1992: Marcell U Heim; Markus Böck; Hans-Jochem Kolb; Michael Schleuning; W Mempel
Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases.
Vox sanguinis 1992;62(3):165-8.
1991: J Hahn; Hans-Jochem Kolb; M Schumm; K Beisser; J Ellwart; P Rieber; J Maldacker; N Schwella; L K Lösslein; Ernst Holler
Immunological characterization of canine hematopoietic progenitor cells.
Annals of hematology 1991;63(4):223-6.
1991: B Gleixner; Hans-Jochem Kolb; Ernst Holler; S Liesenfeld; C Riedner; Erhard Hiller; C Seeber; J Kempeni; A Möller; H Knabe
Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha.
Bone marrow transplantation 1991;8(2):93-8.
1991: C Hötzl; Hans-Jochem Kolb; Ernst Holler; J Hahn; M Schumm; K Beisser; J Mysliwietz; P Rieber; W Mempel; W Wilmanns
Functional characterization of canine lymphocyte subsets.
Annals of hematology 1991;63(1):49-53.
1991: R C Ash; Mary M Horowitz; Robert Peter Gale; D W van Bekkum; James T Casper; Edward C Gordon-Smith; P J Henslee; Hans-Jochem Kolb; B Lowenberg; T Masaoka
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.
Bone marrow transplantation 1991;7(6):443-52.
1991: W Hill; L Greither; Reiner Bartl; Ulrich Jehn; Hans-Jochem Kolb; W Wilmanns
[Patient with decreased energy, dyspnea on exertion and splenomegaly].
Der Internist 1991;32(3):154-7.
1991: Rüdiger Hehlmann; H Heimpel; Barbara Heinze; A Georgii; Hans-Jochem Kolb; Dieter K Hossfeld; P von Wussow; Andreas Hochhaus; Martin Griesshammer; V Diehl
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)].
Onkologie 1991;14(1):66-73.
1991: Ernst Holler; Hans-Jochem Kolb; B Gleixner; C Riedner; Reiner Bartl; Georg Ledderose; A Sönnichsen; W Wilmanns
[18-year-old patient with increasing exertional dyspnea and hemorrhagic diathesis].
Der Internist 1991;32(2):100-3.
1990: Hans-Jochem Kolb; J Mittermüller; C Clemm; Ernst Holler; Georg Ledderose; G Brehm; M Heim; W Wilmanns
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.
Blood 1990;76(12):2462-5.
1990: Hans-Jochem Kolb; Christine Bender-Götze
Late complications after allogeneic bone marrow transplantation for leukaemia.
Bone marrow transplantation 1990;6(2):61-72.
1990: K Atkinson; Mary M Horowitz; Robert Peter Gale; D W van Bekkum; Eliane Gluckman; R A Good; Niels Jacobsen; Hans-Jochem Kolb; A A Rimm; O Ringdén
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation.
Blood 1990;75(12):2459-64.
1990: C Clemm; M Wick; Reiner Bartl; M Goebel; Hans-Jochem Kolb
[Patient with anemia, thrombopenia and slight leukocytosis].
Der Internist 1990;31(6):423-6.
1990: Ernst Holler; Hans-Jochem Kolb; A Möller; J Kempeni; S Liesenfeld; H Pechumer; W Lehmacher; G Ruckdeschel; B Gleixner; C Riedner
Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.
Blood 1990;75(4):1011-6.
1990: Mary M Horowitz; Robert Peter Gale; Paul M Sondel; John M Goldman; J Kersey; Hans-Jochem Kolb; A A Rimm; O Ringdén; C Rozman; B Speck
Graft-versus-leukemia reactions after bone marrow transplantation.
Blood 1990;75(3):555-62.
1990: Hans-Jochem Kolb; L K Lösslein; K Beisser; E Schäffer; Ernst Holler; N Schwella; E Hochhäusser; W Lehmacher; O Balk; S Thierfelder
Dose rate and fractionation of total body irradiation in dogs: short and long term effects.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;18 Suppl 1():51-9.
1989: G Jung; Ernst Holler; Hans-Jochem Kolb; W Wilmanns
[Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)].
Der Internist 1989;30(6):386-8.
1989: Ernst Holler; Hans-Jochem Kolb; Erhard Hiller; W Mraz; W Lehmacher; B Gleixner; C Seeber; U Jehn; HH Gerhartz; G Brehm
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation.
Blood 1989;73(7):2018-24.
1989: Hans-Jochem Kolb; Ernst Holler; Christine Bender-Götze; U Walther; J Mittermüller; C Clemm; M Bauchinger; HH Gerhartz; G Brehm; Georg Ledderose
Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuria.
Bone marrow transplantation 1989;4(1):29-34.
1989: Hans-Jochem Kolb; Christine Bender-Götze; Ernst Holler; J Mittermüller; H Grosse-Wilde; R Wank; R Eckstein; S Scholz; R J Haas; W Mempel
Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
Folia haematologica (Leipzig, Germany : 1928) 1989;116(3-4):421-5.
1989: Hans-Jochem Kolb; Christine Bender-Götze; R J Haas; Ernst Holler; S Thierfelder; W Wilmanns
Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group.
Folia haematologica (Leipzig, Germany : 1928) 1989;116(3-4):397-402.
1988: HH Gerhartz; J Mittermüller; A Raghavachar; Helga Schmetzer; C Clemm; Hans-Jochem Kolb; C C Bartram; Hans Wolf
Epstein-Barr virus-positive recipient type B-cells survive in a "complete chimera" after allogeneic bone-marrow transplantation.
International journal of cancer. Journal international du cancer 1988;42(5):672-6.
1988: Marcell U Heim; Michael Schleuning; R Eckstein; Dieter Huhn; W Siegert; C Clemm; Georg Ledderose; Hans-Jochem Kolb; W Wilmanns; W Mempel
Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation.
Transfusion 1988;28(3):272-5.
1988: J Mysliwietz; G Hoffmann-Fezer; S Thierfelder; Hans-Jochem Kolb; J Maldacker
Recognition of two epitopes of an antigen present on canine T cells but not on hemopoietic progenitors by four monoclonal antibodies.
Transplantation 1988;45(2):443-8.
1987: L K Lösslein; Hans-Jochem Kolb; S Porzsolt; E Schäffer; S Scholz; H Meissner; Ernst Holler; W Wilmanns; S Thierfelder
Hyperfractionation of total-body irradiation and engraftment of marrow from DLA-haploidentical littermates.
Transplantation proceedings 1987;19(1 Pt 3):2707-8.
1986: HH Gerhartz; Hans-Jochem Kolb; C Clemm; W Wilmanns
Clonogenic assays and engraftment in allogeneic bone marrow transplantation.
Bone marrow transplantation 1986;1(2):221-6.
1986: J Mittermüller; Hans-Jochem Kolb; HH Gerhartz; W Wilmanns
In vivo differentiation of leukaemic blasts and effect of low dose Ara-C in a marrow grafted patient with leukaemic relapse.
British journal of haematology 1986;62(4):757-62.
1985: J Mittermüller; Hans-Jochem Kolb; HH Gerhartz; W Wilmanns
Cytotoxic action of low dose Ara-C. Investigations in a marrow grafted patient with relapse.
Onkologie 1985;8(3):168-71.
1984: E Holler; Hans-Jochem Kolb; U Bodenberger; R Eckstein; G Hoffmann-Fezer; R P Linke; W Mempel; H Rodt; S Thierfelder
Serological identification and separation of canine lymphocyte subpopulations.
Experimental hematology 1984;12(10):774-81.
1983: U Jehn; H Sauer; Hans-Jochem Kolb; M Fink; Georg Ledderose; G Brehm; W Wilmanns; R Eckstein; M Heim; W Mempel; H von Lieven; E Bunde; R Rohloff; O Balk; E Hochhäuser
[Bone marrow transplantation in adults in acute leukemia, aplastic anemia and paroxysmal nocturnal hemoglobinuria. Results of the Medical Clinic IIi of LMU (Ludwig-Maximilians University) Munich].
Klinische Wochenschrift 1983;61(7):321-8.
1983: H Rodt; S Thierfelder; Christine Bender-Götze; R Dopfer; F J Haas; G Janka; Hans-Jochem Kolb; H Link; B Netzel; Dietrich Niethammer; K Schüch; K Wilms
Serological inhibition of graft versus host disease: recent results in 28 patients with leukemia.
Haematology and blood transfusion 1983;28():92-6.
1981: H Rodt; B Netzel; Hans-Jochem Kolb; R J Haas; K Wilms; Christine Bender-Götze; Peter Wernet; G Janka; H Link; W Wilmanns; S Thierfelder
[Bone marrow transplantation in acute leukemias: antibody treatment for suppression of graft-versus-host disease (author's transl)].
Blut 1981;43(2):113-8.
1981: Hans-Jochem Kolb; G F Wündisch; I Spitzer; H Ochsler; L Stengel-Rutkowski; Christine Bender-Götze; E D Albert; H Sauer; Georg Ledderose; G Brehm; U Jehn; R Eckstein; W Mempel; W Wilmanns; R J Haas; M Helmig; B Netzel; Bernd H Belohradsky; G Janka; H Rodt; H Grosse-Wilde; E Thiel; H von Lieven; R Roloff; B L Krimmel; E Bunde; R Wank; D Schendel
[Bone marrow transplantation for aplastic anaemia (author's transl)].
Klinische Wochenschrift 1981;59(7):325-42.
1981: Hans-Jochem Kolb; Christine Bender-Götze; E D Albert; R Haas; G Janka
[Bone marrow transplantation for relapsed, acute leukaemia (author's transl)].
Klinische Wochenschrift 1981;59(6):251-66.
1981: H Rodt; Hans-Jochem Kolb; B Netzel; R J Haas; K Wilms; C B Götze; H Link; S Thierfelder
Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT.
Transplantation proceedings 1981;13(1 Pt 1):257-61.
1981: B Netzel; R J Haas; H Rodt; Hans-Jochem Kolb; Bernd H Belohradsky; S Thierfelder
Antileukemic, autologous bone marrow transplantation in childhood acute lymphoblastic leukemia.
Transplantation proceedings 1981;13(1 Pt 1):254-6.
1981: H Rodt; S Thierfelder; Hans-Jochem Kolb; B Netzel; R J Haas; K Wilms; Christine Bender-Götze
The concept of GvHD-suppression by in vitro treatment with antisera.
Haematology and blood transfusion 1981;26():124-35.
1980: H Sauer; U Jehn; Hans-Jochem Kolb; Georg Ledderose; W Wilmanns
[Allogeneic bone marrow transplantation in a patient with bone marrow aplasia].
Der Internist 1980;21(7):400-5.
1980: B Netzel; R J Haas; H Rodt; Hans-Jochem Kolb; S Thierfelder
Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia.
Lancet 1980;1(8182):1330-2.
1980: R J Haas; G Janka; B Netzel; H Rodt; S Thierfelder; M Helmig; R Eife; Bernd H Belohradsky; Hans-Jochem Kolb; K Betke
Antibody incubation of human marrow graft for prevention graft versus host disease.
Blut 1980;40(6):387-97.
1980: Hans-Jochem Kolb; U Bodenberger; H V Rodt; I Rieder; B Netzel; H Grosse-Wilde; S Scholz; S Thierfelder
Bone marrow transplantation in DLA-haploidentical canine littermates: fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG).
Haematology and blood transfusion 1980;25():61-71.